Genfit S.A. (GNFT)
NASDAQ: GNFT · Real-Time Price · USD
4.120
-0.130 (-3.06%)
Oct 14, 2025, 9:55 AM EDT - Market open
Genfit Revenue
Genfit had revenue of 35.54M EUR in the half year ending June 30, 2025, with 135.16% growth. This brings the company's revenue in the last twelve months to 45.13M, down -43.93% year-over-year. In the year 2024, Genfit had annual revenue of 70.69M with 105.01% growth.
Revenue (ttm)
45.13M EUR
Revenue Growth
-43.93%
P/S Ratio
4.00
Revenue / Employee
250,694 EUR
Employees
180
Market Cap
212.02M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 70.69M | 36.21M | 105.01% |
Dec 31, 2023 | 34.48M | 8.24M | 31.38% |
Dec 31, 2022 | 26.25M | -59.11M | -69.25% |
Dec 31, 2021 | 85.36M | 76.67M | 883.14% |
Dec 31, 2020 | 8.68M | -30.29M | -77.72% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
GNFT News
- 21 days ago - GENFIT Reports First-Half 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 24 days ago - GENFIT Announces Discontinuation of its VS-01 Program in ACLF: VS-01 Development Refocused on UCD - GlobeNewsWire
- 3 months ago - Genfit: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial - GlobeNewsWire
- 4 months ago - GENFIT: June 17, 2025 Combined Shareholders Meeting Results - GlobeNewsWire
- 5 months ago - GENFIT Reports First Quarter 2025 Financial Information - GlobeNewsWire
- 5 months ago - GENFIT to receive a €26.5 million milestone payment following the approval of pricing and reimbursement of Ipsen's Iqirvo® in Italy - GlobeNewsWire
- 5 months ago - GENFIT: Publication of the 2025 Extra-Financial Performance Report (fiscal year 2024) - GlobeNewsWire
- 5 months ago - GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Preparatory Documents - GlobeNewsWire